Download this free whitepaper to learn more.
Bringing a therapy to market requires a continuous series of strategic decisions across discovery, development, commercialization, and post-market evaluation. As organizations navigate growing complexity across the medicine lifecycle, the quality, relevance, and timeliness of data have become increasingly important to decision-making.
Among the expanding range of real-world data sources available today, de-identified laboratory data is playing a growing role in helping organizations better understand patient populations, disease progression, treatment response, and healthcare utilization. While electronic health records, billing claims, and prescription data each contribute important perspectives, laboratory data offers an additional layer of clinical insight grounded in objective biological measurements and near-real-time testing information.
Access this whitepaper to explore how timely, precise lab data can support decision-making from discovery through post-market evaluation. You’ll learn about:
- Why lab data can provide deeper visibility into the patient journey
- How lab data may strengthen clinical trial planning and execution
- The growing role of lab data across commercial and health economics strategies
- Why laboratory data is becoming increasingly relevant in the AI era
Offered Free by: Quest Diagnostics
See All Resources from: Quest Diagnostics
